3 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
Follow Tolerability: new trials by email Literature Review of Tolerability trials Research Report on Tolerability
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer Fluzoparib, Apatinib Mesylate - Epithelial Ovarian Cancer, Efficacy | Phase 3 | Unknown | Anhui Provincial Hospital | 51 | 2024-10-01 | 2024-08-06 |
| Phase III Open Study, Prospective, Multicenter, Randomized, Comparative to the Positive Control for Evaluating the Efficacy and Safety of Auris-Sedina in the Symptomatic Control of Otalgy in Patients With or Without Acute External Otitis. Auris-Sedina, Otosynalar® - Otitis, Efficacy | Phase 3 | Unknown | Laboratorios Osorio de Moraes Ltda. | 188 | 2009-12-01 | 2009-08-27 |
| Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety Passiflora, Crataegus e Salix - Anxiety, Efficacy | Phase 3 | Unknown | Ativus Farmaceutica Ltda | 124 | 2009-09-01 | 2009-07-24 |
Anxiety Disorders (1) · Carcinoma, Ovarian Epithelial (1) · Lymphoma, Follicular (1) · Otitis (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Adnexal Diseases (1) · Carcinoma (1) · Ear Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1)
apatinib (1) · fluzoparib (1)
Anhui Provincial Hospital (1) · Ativus Farmaceutica Ltda (1) · Laboratorios Osorio de Moraes Ltda. (1)
Brazil (2)
Elie Fiss (2) · Ying Zhou, MD (1)